ClinicalTrials.gg

Infertility, Male clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 282 studies for Infertility, Male across more than 10 countries. 65 are recruiting or about to start. 204 of them are mainly about Infertility, Male (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-17. Counting its 4 narrower conditions too, such as Oligospermia: 377 studies, 90 open.

Status

Completed
136
Status unknown
50
Recruiting
40
Not yet recruiting
21
Active, not recruiting
13
Terminated
10

Phase

Phase 2
31
Phase 3
20
Phase 4
14
Phase 1
11
Early Phase 1
4

Where

United States
58
Egypt
24
Spain
17
Italy
17
Denmark
13
France
11

Who develops what

Add Infertility, Male to watchlistPro · free during the betaEvery Monday by email · turn it off any time

Every program with a company-led study here in the last two years, whatever its size: 5 programs from 3 companies, 1 with this as their studies’ main aim; 1 with a live phase 3 study; 2 primary completions in the next 12 months. Compare Hamad Medical and Merck KGaA, Darmstadt, Germany here →

Comparator & background therapies

What other companies’ phase 2+ studies give as the comparator or the background here (its leading trial sponsor and partners left out): a sign of what new drugs are measured against, not by itself the standard of care, its prescriptions or its market.

None given by two companies or more yet.

Programs

“Meets, by arms” reads each study’s arms: vs its arm against the therapy’s; + X vs a combination against it; added to it plus the therapy against the therapy; studied with given together only. The next primary completion is the next phase-3 study’s when there is one.

The 5 programs — sign in to see the whole list, free: filter by phase and aim, sort by late development, direct comparisons or the next primary completion.

Primary completion in the next 12 months (2)

Live phase 2 and 3 studies of these programs. Primary completion is when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced.

  • 15 Oct 2027 est.Antioxidants, Clomiphene, Follicle Stimulating Hormone · Hamad Medical Corporation · Phase 4 named, not the main aimNCT07862725 Comparative Efficacy of Antioxidants Alone Versus Combined Therapy With SERMs or FSH in Normogonadotropic Idiopathic OAT Patients: A Randomized Controlled Trial — primary endpoint: Change in Sperm Concentration · 360 enrolled
  • 28 Oct 2027 est.Intravaginal gel · Prokrea BCN, S.L. · Phase 3 named, not the main aimNCT07669584 PKB171 Against Placebo in Couples With Mild Male Factor Infertility — primary endpoint: To assess the efficacy up to three treaament cycles with Gel PKB171 compared with placebo in couples with mild male factor fertility · 732 enrolled

Read from ClinicalTrials.gov, industry-led studies. Main aim: this is the study’s judged main condition; named, not the main aim: the sponsor names it, the study is about something else; registry mapping only: only the registry’s mapping put it here. Leading trial sponsor is the company leading the most industry studies of a drug, a measure of trial activity, not of rights. US and EU rights, and Approved: from the regulators’ records (FDA’s Drugs@FDA via openFDA; EMA’s medicines data) — the holder of a marketed or authorized original, generics and other companies’ versions; not rights elsewhere, nor approval for this condition. Phase 4 trial recorded, where neither lists it: a phase 4 study exists somewhere. Not read yet: labels by indication, exclusivity, licenses, line of therapy, academic comparators, sales.

What is being tested here

Drugs under test in Infertility, Male studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Aromatase inhibitors 4

Coming up

27studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 40 Infertility, Male studies recruiting now, 16 (40%) set no upper age limit and 24 (60%) stop at 75 or younger. 7 (18%) take children under 18. 0 (0%) are for women only and 32 (80%) for men only; 14 (35%) take healthy volunteers.

Recruiting studies that take each age, of 40
AgeWomenMen
102 (5%)7 (18%)
186 (15%)35 (88%)
307 (18%)39 (98%)
406 (15%)38 (95%)
505 (13%)28 (70%)
654 (10%)16 (40%)
754 (10%)16 (40%)
854 (10%)16 (40%)

Across all 282 studies, recruiting or not: 72% stop at 75 or younger and 71% at 65; 10% take children; 5% are for women only and 76% for men only; 34% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Infertility, Male studies take

Of 92 interventional studies with no phase under Infertility, Male, half reached primary completion within 34 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase34 mo17–50 · 92 studies—28 mo17–50 · 77 studies
Observational59 mo21–129 · 40 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 19, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 282. Browse all 282 → or search them.